G2GBIO Surges on Chinese Pharma Tie-Up; Inventera Gets Positive Signal on U.S. Trial [Bio Market Briefing]
Predicted impact: Low
China platform evaluation partnership already reported in the past 14 days; undisclosed value.
Comments
No comments yet. Start the conversation.
Comments are people's own views. Nothing here is financial advice.